angiotensin ii, des-phe(8)- has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El Fattah, MA; Abdallah, DM; El-Abhar, HS; Nassar, NN; Rabie, MA | 2 |
2 other study(ies) available for angiotensin ii, des-phe(8)- and Parkinsonian Disorders
| Article | Year |
|---|---|
Correlation between angiotensin 1-7-mediated Mas receptor expression with motor improvement, activated STAT3/SOCS3 cascade, and suppressed HMGB-1/RAGE/NF-κB signaling in 6-hydroxydopamine hemiparkinsonian rats.
Topics: Angiotensin I; Animals; Corpus Striatum; Dopaminergic Neurons; Gene Expression; HMGB1 Protein; Male; Motor Activity; NF-kappa B; Oxidopamine; Parkinsonian Disorders; Peptide Fragments; Proteins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, G-Protein-Coupled; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Vasodilator Agents | 2020 |
Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor/PI3K/Akt/BDNF pathway and inhibition of angiotensin II type-1 receptor/NF-κB axis.
Topics: Angiotensin I; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Corpus Striatum; Male; NF-kappa B; Oxidopamine; Parkinsonian Disorders; Peptide Fragments; Phosphatidylinositol 3-Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction | 2018 |